Autonomix Medical Completes Pre-Submission Meeting With FDA For Its Transvascular Sensing Platform
Autonomix Medical, Inc. (NASDAQ: AMIX ) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the successful completion of a pre-submission meeting with the U.S. Food and Drug Administration (FDA) regarding the Company’s recently announced s